Article info
Extended essay
SARS-CoV-2 safer infection sites: moral entitlement, pragmatic harm reduction strategy or ethical outrage?
- Correspondence to Ms Megan F Hunt, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; mhunt25{at}jhmi.edu
Citation
SARS-CoV-2 safer infection sites: moral entitlement, pragmatic harm reduction strategy or ethical outrage?
Publication history
- Received June 7, 2020
- Revised October 20, 2020
- Accepted November 16, 2020
- First published December 9, 2020.
Online issue publication
November 29, 2021
Article Versions
- Previous version (9 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Physical activity and risk of infection, severity and mortality of COVID-19: a systematic review and non-linear dose–response meta-analysis of data from 1 853 610 adults
- Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic
- Temporal variations in the severity of COVID-19 illness by race and ethnicity
- Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England
- Acute covid-19 and multisystem inflammatory syndrome in children
- Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
- SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
- Uneventful case of COVID-19 in a kidney transplant recipient
- 2021 Southern Medical Research Conference
- Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study